tirzepatide fda submission approves new weight-loss drug Zepbound (tirzepatide) Utide's Tirzepatide & Retatrutide DMF

Personal or family history of medullary thyroid carcinoma 2

Licensed 503A compounding follows strict FDA oversight and state pharmacy board regulations, ensuring sterility, potency, and safety identical to mass-manufactured drugs

The liquid chromatography (LC) gradient program was: 98% B for 1 minute, followed by a linear decrease to 40% B within 5 minutes, then maintaining 40% B for 13 minutes, then returning to 98% B in 1 minute and finally 5 minutes 98% B for column equilibration

GLP-1-induced slowing of gastric motility theoretically could reduce levothyroxine bioavailability, though clinical studies show minimal direct interaction in most patients